Comparison of the in vitro Anti-Inflammatory Effect of Cannabidiol to Dexamethasone

References

• Chen L, Deng H, Cui H, et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2017;9(6):7204–7218. doi:10.18632/oncotarget.23208
   PubMedGoogle Scholar
• Tang J, Diao P, Shu X, Li L, Xiong L. Quercetin and Quercitrin Attenuates the Inflammatory Response and Oxidative Stress in LPS-Induced RAW264.7 Cells: in vitro Assessment and a Theoretical Model. BioMed Res Int. 2019;2019:7039802. doi:10.1155/2019/7039802
   PubMed Web of Science ®Google Scholar
• Gutierrez RMP, Hoyo-Vadillo C. Anti-inflammatory potential of Petiveria alliacea on activated RAW264.7 murine macrophages. Pharmacogn Mag. 2017;13(50):174. doi:10.4103/pm.pm_479_16
   Web of Science ®Google Scholar
• Lee HN, Shin SA, Choo GS, et al. Anti‑inflammatory effect of quercetin and galangin in LPS‑stimulated RAW264.7 macrophages and DNCB‑induced atopic dermatitis animal models. Int J Mol Med. 2018;41(2):888–898. doi:10.3892/ijmm.2017.3296
   PubMed Web of Science ®Google Scholar
• Fujiwara N, Kobayashi K. Macrophages in inflammation. Curr Drug Targets Inflamm Allergy. 2005;4(3):281–286. doi:10.2174/1568010054022024
   PubMedGoogle Scholar
• Aki T, Funakoshi T, Noritake K, Unuma K, Uemura K. Extracellular glucose is crucially involved in the fate decision of LPS-stimulated RAW264.7 murine macrophage cells. Sci Rep. 2020;10(1):10581. doi:10.1038/s41598-020-67396-6
   PubMed Web of Science ®Google Scholar
• Dorrington MG, Fraser IDC. NF-κB Signaling in Macrophages: dynamics, Crosstalk, and Signal Integration. Front Immunol. 2019;4:10.
   Google Scholar
• Ju M, Liu B, He H, et al. MicroRNA-27a alleviates LPS-induced acute lung injury in mice via inhibiting inflammation and apoptosis through modulating TLR4/MyD88/NF-κB pathway. Cell Cycle Georget Tex. 2018;17(16):2001–2018. doi:10.1080/15384101.2018.1509635
   PubMed Web of Science ®Google Scholar
• Bode JG, Ehlting C, Häussinger D. The macrophage response towards LPS and its control through the p38(MAPK)-STAT3 axis. Cell Signal. 2012;24(6):1185–1194. doi:10.1016/j.cellsig.2012.01.018
   PubMed Web of Science ®Google Scholar
• Chuang TY, Cheng AJ, Chen IT, et al. Suppression of LPS-induced inflammatory responses by the hydroxyl groups of dexamethasone. Oncotarget. 2017;8(30):49735–49748. doi:10.18632/oncotarget.17683
   PubMedGoogle Scholar
• Jain S, Dash P, Minz AP, et al. Lipopolysaccharide (LPS) enhances prostate cancer metastasis potentially through NF-κB activation and recurrent dexamethasone administration fails to suppress it in vivo. The Prostate. 2019;79(2):168–182. doi:10.1002/pros.23722
   PubMed Web of Science ®Google Scholar
• Johnson DB, Lopez MJ, Kelley B. Dexamethasone. StatPearls Publishing; 2022.
   Google Scholar
• Ramadan DT, Ali MAM, Yahya SM, El-Sayed WM. Correlation between antioxidant/antimutagenic and antiproliferative activity of some phytochemicals. Anticancer Agents Med Chem. 2019;19(12):1481–1490. doi:10.2174/1871520619666190528091648
   PubMed Web of Science ®Google Scholar
• Guo M, Marek L, Liang Y, Saw PE. Transforming tea catechins into potent anticancer compound: analysis of three boronated-PEG delivery system. Micromachines. 2021;13:1. doi:10.3390/mi13010045
   PubMed Web of Science ®Google Scholar
• Oyenihi AB, Smith C. Are polyphenol antioxidants at the root of medicinal plant anti-cancer success? J Ethnopharmacol. 2019;229:54–72. doi:10.1016/j.jep.2018.09.037
   PubMed Web of Science ®Google Scholar
• Robaina Cabrera CL, Keir-Rudman S, Horniman N, Clarkson N, Page C. The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination. Pulm Pharmacol Ther. 2021;69:102047. doi:10.1016/j.pupt.2021.102047
   PubMed Web of Science ®Google Scholar
• De Filippis D, Esposito G, Cirillo C, et al. Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis. PLoS One. 2011;6(12):e28159. doi:10.1371/journal.pone.0028159
   PubMed Web of Science ®Google Scholar
• Lowin T, Tingting R, Zurmahr J, Classen T, Schneider M, Pongratz G. Cannabidiol (CBD): a killer for inflammatory rheumatoid arthritis synovial fibroblasts. Cell Death Dis. 2020;11(8):1–11. doi:10.1038/s41419-020-02892-1
   PubMed Web of Science ®Google Scholar
• Sangiovanni E, Fumagalli M, Pacchetti B, et al. Cannabis sativa L. extract and cannabidiol inhibit in vitro mediators of skin inflammation and wound injury. Phytother Res PTR. 2019;33(8):2083–2093. doi:10.1002/ptr.6400
   PubMed Web of Science ®Google Scholar
• Baswan SM, Klosner AE, Glynn K, et al. Therapeutic potential of cannabidiol (CBD) for skin health and disorders. Clin Cosmet Investig Dermatol. 2020;13:927–942. doi:10.2147/CCID.S286411
   PubMed Web of Science ®Google Scholar
• Bíró T, Tóth BI, Haskó G, Paus R, Pacher P. The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities. Trends Pharmacol Sci. 2009;30(8):411–420. doi:10.1016/j.tips.2009.05.004
   PubMed Web of Science ®Google Scholar
• Chye Y, Christensen E, Solowij N, Yücel M. The endocannabinoid system and cannabidiol’s promise for the treatment of substance use disorder. Front Psychiatry. 2019;10:63. doi:10.3389/fpsyt.2019.00063
   PubMed Web of Science ®Google Scholar
• Elsaid S, Kloiber S, Le Foll B. Chapter two - effects of cannabidiol (CBD) in neuropsychiatric disorders: a review of pre-clinical and clinical findings. Rahman S, editor. Progress in Molecular Biology and Translational Science. Vol. 167. Molecular Basis of Neuropsychiatric Disorders: from Bench to Bedside. Academic Press; 2019. 25–75. doi:10.1016/bs.pmbts.2019.06.005
   Google Scholar
• Prud’homme M, Cata R, Jutras-Aswad D. Cannabidiol as an intervention for addictive behaviors: a systematic review of the evidence. Subst Abuse Res Treat. 2015;9:33–38. doi:10.4137/SART.S25081
   PubMed Web of Science ®Google Scholar
• Petrosino S, Verde R, Vaia M, Allarà M, Iuvone T, Di Marzo V. Anti-inflammatory properties of cannabidiol, a nonpsychotropic cannabinoid, in experimental allergic contact dermatitis. J Pharmacol Exp Ther. 2018;365(3):652–663. doi:10.1124/jpet.117.244368
   PubMed Web of Science ®Google Scholar
• Maayah ZH, Takahara S, Ferdaoussi M, Dyck JRB. The anti-inflammatory and analgesic effects of formulated full-spectrum cannabis extract in the treatment of neuropathic pain associated with multiple sclerosis. Inflamm Res off J Eur Histamine Res Soc Al. 2020;69(6):549–558. doi:10.1007/s00011-020-01341-1
   Web of Science ®Google Scholar
• Burstein S. Cannabidiol (CBD) and its analogs: a review of their effects on inflammation. Bioorg Med Chem. 2015;23(7):1377–1385. doi:10.1016/j.bmc.2015.01.059
   PubMed Web of Science ®Google Scholar
• Citti C, Russo F, Linciano P, et al. Origin of Δ9-tetrahydrocannabinol impurity in synthetic cannabidiol. Cannabis Cannabinoid Res. 2021;6(1):28–39. doi:10.1089/can.2020.0021
   PubMedGoogle Scholar
• Zhou J, Zhou Q, Zhang T, Fan J. C7ORF41 regulates inflammation by inhibiting NF-κB signaling pathway. BioMed Res Int. 2021;2021:e7413605. doi:10.1155/2021/7413605
   PubMed Web of Science ®Google Scholar
• Schulze-Osthoff K, Ferrari D, Riehemann K, Wesselborg S. Regulation of NF-κB activation by MAP kinase cascades. Immunobiology. 1997;198(1):35–49. doi:10.1016/S0171-2985(97)
   PubMed Web of Science ®Google Scholar
• Alam MB, Chowdhury NS, Sohrab MH, Rana MS, Hasan CM, Lee SH. Cerevisterol alleviates inflammation via suppression of MAPK/NF-κB/AP-1 and activation of the Nrf2/HO-1 signaling cascade. Biomolecules. 2020;10(2):199. doi:10.3390/biom10020199
   PubMed Web of Science ®Google Scholar
• Maldonado RF, Sá-Correia I, Valvano MA. Lipopolysaccharide modification in Gram-negative bacteria during chronic infection. FEMS Microbiol Rev. 2016;40(4):480–493. doi:10.1093/femsre/fuw007
   PubMed Web of Science ®Google Scholar
• Laskin DL, Pendino KJ. Macrophages and inflammatory mediators in tissue injury. Annu Rev Pharmacol Toxicol. 1995;35:655–677. doi:10.1146/annurev.pa.35.040195.003255
   PubMed Web of Science ®Google Scholar
• Li P, Xu Y, Cao Y, Ding Z. Polypeptides isolated from Lactococcus lactis alleviates lipopolysaccharide (LPS)-induced inflammation in Ctenopharyngodon idella. Int J Mol Sci. 2022;23(12):6733. doi:10.3390/ijms23126733
   PubMed Web of Science ®Google Scholar
• Hu K, Yang Y, Tu Q, Luo Y, Ma R. Alpinetin inhibits LPS-induced inflammatory mediator response by activating PPAR-γ in THP-1-derived macrophages. Eur J Pharmacol. 2013;721(1–3):96–102. doi:10.1016/j.ejphar.2013.09.049
   PubMed Web of Science ®Google Scholar
• Sharma JN, Al-Omran A, Parvathy SS. Role of nitric oxide in inflammatory diseases. Inflammopharmacology. 2007;15(6):252–259. doi:10.1007/s10787-007-0013-x
   PubMedGoogle Scholar
• Dong J, Li J, Cui L, et al. Cortisol modulates inflammatory responses in LPS-stimulated RAW264.7 cells via the NF-κB and MAPK pathways. BMC Vet Res. 2018;14(1):30. doi:10.1186/s12917-018-1360-0
   PubMed Web of Science ®Google Scholar
• Tabarsa M, Dabaghian EH, You S, et al. The activation of NF-κB and MAPKs signaling pathways of RAW264.7 murine macrophages and natural killer cells by fucoidan from Nizamuddinia zanardinii. Int J Biol Macromol. 2020;148:56–67. doi:10.1016/j.ijbiomac.2020.01.125
   PubMed Web of Science ®Google Scholar
• Khan MI, Sobocińska AA, Czarnecka AM, Król M, Botta B, Szczylik C. The therapeutic aspects of the Endocannabinoid System (ECS) for cancer and their development: from nature to laboratory. Curr Pharm Des. 2016;22(12):1756–1766. doi:10.2174/1381612822666151211094901
   PubMed Web of Science ®Google Scholar
• Monga S, Fares B, Yashaev R, et al. The effect of Natural-Based Formulation (NBF) on the response of RAW264.7 macrophages to LPS as an in vitro model of inflammation. J Fungi. 2022;8(3):321. doi:10.3390/jof8030321
   Web of Science ®Google Scholar
• Muthumalage T, Rahman I. Cannabidiol differentially regulates basal and LPS-induced inflammatory responses in macrophages, lung epithelial cells, and fibroblasts. Toxicol Appl Pharmacol. 2019;382:114713. doi:10.1016/j.taap.2019.114713
   PubMed Web of Science ®Google Scholar
• Ali A, Akhtar N. The safety and efficacy of 3% Cannabis seeds extract cream for reduction of human cheek skin sebum and erythema content. Pak J Pharm Sci. 2015;28(4):1389–1395.
   PubMed Web of Science ®Google Scholar
• Yuan C, Wang XM, Guichard A, et al. N-palmitoylethanolamine and N-acetylethanolamine are effective in asteatotic eczema: results of a randomized, double-blind, controlled study in 60 patients. Clin Interv Aging. 2014;9:1163–1169. doi:10.2147/CIA.S65448
   PubMed Web of Science ®Google Scholar
• Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454(7203):428–435. doi:10.1038/nature07201
   PubMed Web of Science ®Google Scholar
• Arulselvan P, Fard MT, Tan WS, et al. Role of antioxidants and natural products in inflammation. Oxid Med Cell Longev. 2016;2016:5276130. doi:10.1155/2016/5276130
   PubMed Web of Science ®Google Scholar
• Elisia I, Pae HB, Lam V, Cederberg R, Hofs E, Krystal G. Comparison of RAW264.7, human whole blood and PBMC assays to screen for immunomodulators. J Immunol Methods. 2018;452:26–31. doi:10.1016/j.jim.2017.10.004
   PubMed Web of Science ®Google Scholar
• Wang X, Hu X, Yan H, Ma Z, Deng X. Pro-inflammatory effects of a litchi protein extract in murine RAW264.7 macrophages. Hortic Res. 2016;3(1):1–7. doi:10.1038/hortres.2016.17
   Web of Science ®Google Scholar
• Hammouda MB, Ford AE, Liu Y, Zhang JY. The JNK signaling pathway in inflammatory skin disorders and cancer. Cells. 2020;9(4):857. doi:10.3390/cells9040857
   PubMed Web of Science ®Google Scholar